Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 0 | 0 | 0 | 0 | 12,595 |
| Gross Profit | N/A | N/A | N/A | N/A | 12,595 |
| Operating Expenses | 47,232 | 40,270 | 43,280 | 42,621 | 37,525 |
| Operating Income | -47,232 | -40,270 | -43,280 | -42,621 | -24,930 |
| Other Income | 11,230 | 12,082 | 9,858 | 9,553 | 10,578 |
| Pre-tax Income | -36,002 | -28,188 | -33,422 | -33,068 | -14,352 |
| Income Tax | 2,214 | 2,362 | -1,181 | 1,232 | 1,199 |
| Net Income Continuous | -38,216 | -30,550 | -32,241 | -34,300 | -15,551 |
| Net Income | $-38,216 | $-30,550 | $-32,241 | $-34,300 | $-15,551 |
| EPS Basic Total Ops | -1.07 | -0.85 | -0.90 | -0.96 | -0.44 |
| EPS Basic Continuous Ops | -1.07 | -0.85 | -0.90 | -0.96 | -0.44 |
| EPS Diluted Total Ops | -1.07 | -0.85 | -0.90 | -0.96 | -0.44 |
| EPS Diluted Continuous Ops | -1.07 | -0.85 | -0.90 | -0.96 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -1.07 | -0.85 | -0.90 | N/A | N/A |
| EBITDA(a) | $-49,668 | $-50,277 | $-37,670 | $-47,782 | $-24,708 |